These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2231810)

  • 1. Use of recombinant human erythropoietin (r-HuEPO) in a Jehovah's Witness refusing transfusion of blood products: case report.
    Koestner JA; Nelson LD; Morris JA; Safcsak K
    J Trauma; 1990 Nov; 30(11):1406-8. PubMed ID: 2231810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant human erythropoietin for a Jehovah's Witness with anemia of thermal injury.
    Boshkov LK; Tredget EE; Janowska-Wieczorek A
    Am J Hematol; 1991 May; 37(1):53-4. PubMed ID: 2024641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant human erythropoietin in the anemia of prematurity: results of a placebo-controlled pilot study.
    Shannon KM; Mentzer WC; Abels RI; Freeman P; Newton N; Thompson D; Sniderman S; Ballard R; Phibbs RH
    J Pediatr; 1991 Jun; 118(6):949-55. PubMed ID: 2040933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Death after refusing treatment--causality assessment using the example of a Jehovah's Witness].
    Gebhardt K; Bartsch C
    Arch Kriminol; 2009; 224(5-6):192-7. PubMed ID: 20069777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of recombinant human erythropoietin to avoid blood transfusion in a Jehovah's Witness requiring hemispherectomy. Case report.
    Schiff SJ; Weinstein SL
    J Neurosurg; 1993 Oct; 79(4):600-2. PubMed ID: 8410232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
    Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
    Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe Acute Anemia After Liver Transplantation in an Elderly Jehovah's Witness Treated With High-dose Erythropoietin and Ferric Carboxymaltose: A Case Report.
    Brunetta DM; Kaufman J; De Santis GC; Mesquita DF; Souza FN; Garcia JH
    Transplant Proc; 2015 Oct; 47(8):2548-51. PubMed ID: 26518969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of recombinant human erythropoietin in a Jehovah's Witness.
    Koenig HM; Levine EA; Resnick DJ; Meyer WJ
    J Clin Anesth; 1993; 5(3):244-7. PubMed ID: 8318245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhancement of erythropoiesis by recombinant human erythropoietin in low birth weight infants: a pilot study.
    Shannon KM; Mentzer WC; Abels RI; Wertz M; Thayer-Moriyama J; Li WY; Thompson D; Decelle S; Phibbs RH
    J Pediatr; 1992 Apr; 120(4 Pt 1):586-92. PubMed ID: 1372652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe anemia in the Jehovah's Witness: case report and discussion.
    Collins SL; Timberlake GA
    Am J Crit Care; 1993 May; 2(3):256-9. PubMed ID: 8364678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative use of recombinant human erythropoietin in patients refusing blood transfusions. Pathophysiological considerations based on 5 cases.
    Wolff M; Fandrey J; Hirner A; Jelkmann W
    Eur J Haematol; 1997 Mar; 58(3):154-9. PubMed ID: 9150708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of erythropoietin in Jehovah's Witness children following acute gastrointestinal blood loss.
    Smith SN; Milov DE
    J Fla Med Assoc; 1993 Feb; 80(2):103-5. PubMed ID: 8455008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Jehovah's Witnesses: unique problems in a unique trauma population.
    Victorino G; Wisner DH
    J Am Coll Surg; 1997 May; 184(5):458-68. PubMed ID: 9145065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of different dosing regimens for recombinant human erythropoietin in a simulated perisurgical setting: the importance of iron availability in optimizing response.
    Rutherford CJ; Schneider TJ; Dempsey H; Kirn DH; Brugnara C; Goldberg MA
    Am J Med; 1994 Feb; 96(2):139-45. PubMed ID: 8109598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of post-traumatic acute anemia by recombinant human erythropoietin in Jehovah's Witnesses].
    Streef C; Charpentier C; Audibert G; Laxenaire MC
    Ann Fr Anesth Reanim; 1996; 15(8):1199-202. PubMed ID: 9636794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The perioperative use of recombinant erythropoietin (rhEPO) in Jehovah's witnesses].
    Soukup J; Menzel M; Roth S; Radke J
    Anaesthesist; 1996 Aug; 45(8):745-9. PubMed ID: 8967587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
    Phair JP; Abels RI; McNeill MV; Sullivan DJ
    Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Massive obstetric hemorrhage in a Jehovah's Witness: intraoperative strategies and high-dose erythropoietin use.
    Belfort M; Kofford S; Varner M
    Am J Perinatol; 2011 Mar; 28(3):207-10. PubMed ID: 20827658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Successful use of recombinant human erythropoietin in a Jehovah's Witness with a thermal injury.
    Deitch EA; Guillory D; Cruz N
    J Burn Care Rehabil; 1994; 15(1):42-5. PubMed ID: 8150842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hemorrhagic surgery in two Jehova's witness children refusing programmed autotransfusion: a place for erythropoietin].
    Roure P; Hayem C; Daoud A
    Ann Fr Anesth Reanim; 1998; 17(4):310-4. PubMed ID: 9750750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.